Chinese import law postponed
This article was originally published in The Gray Sheet
Executive Summary
China's government indefinitely postpones implementation of regulations that U.S. manufacturers say would otherwise delay device imports into China. Decree 95, or Administrative Measures on Examination and Supervision of Imported Medical Devices, was originally scheduled to take effect Dec. 1 (1"The Gray Sheet" Nov. 5, 2007, p. 3). Though China's Administration of Quality Supervision, Inspection, and Quarantine (AQSIQ) states that the implementation deadline will be "subsequently announced," an AdvaMed spokesperson says that "this type of indefinite suspension generally means Decree 95 is dead, unless AQSIQ re-initiates the rulemaking process at some future date.
You may also be interested in...
U.S. Officials, Industry See Border Delays In Impending China Import Reg
U.S. officials with the World Trade Organization and the U.S. device industry are challenging China's government on pending regulations they say will create unnecessary delays in getting devices into China and onto its market
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.